(2R,3R)-1-<(tert-butyldimethylsilyl)oxy>-3-<(tert-butoxycarbonyl)amino>-3-phenyl-2-propanol | 153704-74-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (2R,3R)-1-<(tert-butyldimethylsilyl)oxy>-3-<(tert-butoxycarbonyl)amino>-3-phenyl-2-propanol
• 英文别名: (2R,3R)-3-tert-butoxycarbonylamino-1-tert-butyldimethylsilyloxy-2-hydroxy-3-phenylpropane；tert-butyl [(1R,2R)-3-{[tert-butyl(dimethyl)silyl]oxy}-2-hydroxy-1-phenylpropyl]carbamate；tert-butyl[(1R,2R)-3-{[tert-butyl(dimethyl)silyl]oxy}-2-hydroxy-1-phenylpropyl]carbamate；tert-butyl N-[(1R,2R)-3-[tert-butyl(dimethyl)silyl]oxy-2-hydroxy-1-phenylpropyl]carbamate
• CAS: 153704-74-6
• 化学式: C₂₀H₃₅NO₄Si
• 分子量: 381.588
• InChiKey: FTTGEHSUKNMFER-DLBZAZTESA-N

物化性质

• 沸点：
  464.9±45.0 °C(Predicted)
• 密度：
  1.021±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.64
• 重原子数：
  26
• 可旋转键数：
  9
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  67.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (2R,3R)-1-<(tert-butyldimethylsilyl)oxy>-3-<(tert-butoxycarbonyl)amino>-3-phenyl-2-propanol 在 ruthenium trichloride 、 sodium periodate 、 i-PrNEt 作用下， 以 四氯化碳 、 二氯甲烷 、 水 、 乙腈 为溶剂， 反应 68.0h， 生成 (2S,3R)-2-tert-butoxycarbonylamino-4-tert-butyldimethylsilyloxy-3-methoxymethyloxybutanoic acid
  参考文献：
  名称：

  Total synthesis of mugineic acid. Efficient use of the phenyl group as the carboxyl synthon

  摘要：

  Stereoselective total synthesis of mugineic acid (1), a unique phytosiderophore from roots of barley, has been achieved from madily available (2S,3S)- and (2R,3R)-2,3-epoxycinnamyl alcohols (5) and (6). The key step is the oxidation of the phenyl group to the carboxylic acid by use of the ruthenium trichloride-sodium metaperiodate system.

  DOI：

  10.1016/s0040-4020(01)88039-x
• 作为产物：
  描述：

  苯基甘油醇 在 palladium on activated charcoal 4-二甲氨基吡啶 、 sodium azide 、 甲酸铵 、 碳酸氢钠 、 氯化铵 、 三乙胺 作用下， 以 1,4-二氧六环 、 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 36.0h， 生成 (2R,3R)-1-<(tert-butyldimethylsilyl)oxy>-3-<(tert-butoxycarbonyl)amino>-3-phenyl-2-propanol
  参考文献：
  名称：

  Total synthesis of mugineic acid. Efficient use of the phenyl group as the carboxyl synthon

  摘要：

  Stereoselective total synthesis of mugineic acid (1), a unique phytosiderophore from roots of barley, has been achieved from madily available (2S,3S)- and (2R,3R)-2,3-epoxycinnamyl alcohols (5) and (6). The key step is the oxidation of the phenyl group to the carboxylic acid by use of the ruthenium trichloride-sodium metaperiodate system.

  DOI：

  10.1016/s0040-4020(01)88039-x

文献信息

• IMIDAZOPYRIDINE COMPOUNDS
  申请人：Astellas Pharma Inc.

  公开号：US20140088080A1

  公开（公告）日：2014-03-27

  [Problem] An excellent drug for treating or preventing cardiovascular diseases, based on cGMP production enhancing action due to soluble guanylate cyclase activating action, is provided. [Means for Solution] It was found that imidazopyridine compounds having a carbamoyl group at the 3-position and a substituent bonded at the 8-position via an oxygen atom in an imidazo[1,2-a]pyridine skeleton exhibits a cGMP production enhancing action by a potent soluble guanylate cyclase activating action, and is useful as a drug for treating or preventing various soluble guanylate cyclase-related cardiovascular diseases, thereby completing the present invention.

  提供一种用于治疗或预防心血管疾病的优秀药物，其基于可溶性鸟苷酸环化酶激活作用增强cGMP产生的作用。发现在咪唑吡啶骨架中，3-位具有羰胺基团，8-位通过氧原子与取代基键合的咪唑并[1,2-a]吡啶化合物表现出通过强效可溶性鸟苷酸环化酶激活作用增强cGMP产生的作用，并可用作治疗或预防各种可溶性鸟苷酸环化酶相关心血管疾病的药物，从而完成本发明。
• Imidazopyridine compounds
  申请人：Astellas Pharma Inc.

  公开号：US09447090B2

  公开（公告）日：2016-09-20

  An excellent drug for treating or preventing cardiovascular diseases, based on cGMP production enhancing action due to soluble guanylate cyclase activating action, is provided. It was found that imidazopyridine compounds having a carbamoyl group at the 3-position and a substituent bonded at the 8-position via an oxygen atom in an imidazo[1,2-a]pyridine skeleton exhibits a cGMP production enhancing action by a potent soluble guanylate cyclase activating action, and is useful as a drug for treating or preventing various soluble guanylate cyclase-related cardiovascular diseases, thereby completing the present invention.

  提供了一种基于可溶性鸟苷酸环化酶活化作用的cGMP产生增强作用的出色药物，用于治疗或预防心血管疾病。发现在咪唑吡啶骨架中，具有3-位上的氨甲酰基和通过氧原子与8-位键合的取代基的咪唑[1,2-a]吡啶化合物表现出强效的可溶性鸟苷酸环化酶活化作用，可用作治疗或预防各种可溶性鸟苷酸环化酶相关心血管疾病的药物，从而完成了本发明。
• Synthesis of <i>N</i>-Boc-β-Aryl Alanines and of <i>N</i>-Boc-β-Methyl-β-aryl Alanines by Regioselective Ring-Opening of Enantiomerically Pure <i>N</i>-Boc-Aziridines
  作者：Eva Medina、Albert Moyano、Miquel A. Pericàs、Antoni Riera

  DOI：10.1021/jo981140i

  日期：1998.11.1
• Total synthesis of mugineic acid. Efficient use of the phenyl group as the carboxyl synthon
  作者：Fumiyoshi Matsuura、Yasumasa Hamada、Takayuki Shioiri

  DOI：10.1016/s0040-4020(01)88039-x

  日期：1993.9

  Stereoselective total synthesis of mugineic acid (1), a unique phytosiderophore from roots of barley, has been achieved from madily available (2S,3S)- and (2R,3R)-2,3-epoxycinnamyl alcohols (5) and (6). The key step is the oxidation of the phenyl group to the carboxylic acid by use of the ruthenium trichloride-sodium metaperiodate system.